View Article

Abstract

Acetylcholine (ACh) represents one of the most extensively studied neurotransmitters in the nervous system, serving as a critical mediator of synaptic transmission across both central and peripheral neural networks. This review synthesizes current understanding of acetylcholine's multifaceted roles in neural communication, from its molecular structure and synthesis to its complex physiological functions. The neurotransmitter's unique position as both an excitatory and modulatory agent is examined through its interactions with nicotinic and muscarinic receptor systems. We explore the historical development of acetylcholine research, particularly the pioneering work that established its role in neuromuscular transmission and cardiac regulation. The review addresses the molecular mechanisms underlying acetylcholine synthesis via choline acetyltransferase, its vesicular storage, calcium-dependent release, and subsequent degradation by acetylcholinesterase. Special attention is given to the experimental approaches that have shaped our understanding, including artificial synapse models and the effects of anticholinesterase compounds. The physiological significance of acetylcholine in various contexts, from neuromuscular junction transmission to cardiac muscle modulation, is discussed alongside emerging concepts in electrical transmission and junction potentials. This comprehensive analysis provides insights into the fundamental principles governing cholinergic neurotransmission and its broader implications for nervous system function.

Keywords

Acetylcholine, Mediated Synaptic Transmission, Molecular Mechanisms, Physiological Significance, Neural Communication

Introduction

The discovery and characterization of acetylcholine as a neurotransmitter represents a cornerstone achievement in neuroscience, fundamentally transforming our understanding of how neurons communicate within complex biological systems. Since its initial identification, acetylcholine has emerged as a prototypical neurotransmitter, serving as a model system for understanding the general principles of chemical synaptic transmission. The molecule's relatively simple structure belies its profound physiological importance, as it orchestrates critical functions ranging from voluntary muscle movement to autonomic regulation and cognitive processes. The historical trajectory of acetylcholine research reflects the evolution of neuroscientific methodology itself, from early pharmacological studies to sophisticated molecular investigations. Early researchers faced the fundamental challenge of understanding how electrical signals in neurons could be transmitted across the physical gaps separating cells. The identification of acetylcholine as a chemical mediator provided the first concrete evidence for chemical synaptic transmission, establishing a paradigm that would extend to numerous other neurotransmitter systems.

Molecular Structure and Biosynthesis of Acetylcholine

Acetylcholine exhibits a deceptively simple molecular architecture that encompasses profound functional complexity. The neurotransmitter comprises an acetyl group (CH3CO-) covalently bound to a choline molecule, resulting in the chemical formula C7H16NO2+. This structural simplicity enables rapid synthesis and degradation, characteristics essential for precise temporal control of synaptic signalling. The biosynthetic pathway for acetylcholine synthesis occurs within presynaptic terminals through the enzymatic action of choline acetyltransferase (ChAT). Nachmansohn (1946) et al. demonstrated the critical importance of this enzyme system in maintaining acetylcholine production capacity in peripheral nerves. The reaction utilizes acetyl coenzyme A (acetyl-CoA) as the acetyl donor and choline as the acceptor molecule. Osterhout and Hill (1930) et al. provided early insights into the metabolic coupling between cellular energetics and neurotransmitter production through their salt bridge experiments. The acetyl moiety, derived from central metabolic pathways, represents a crucial link between cellular energetics and neurotransmitter synthesis.

Fig.1. Molecular structure of Acetylcholine

Choline, the other essential substrate, functions as a quaternary ammonium compound containing a positively charged nitrogen atom. Hodgkin (1939) et al. established fundamental principles regarding the ionic basis of membrane potential changes that influence choline transport mechanisms. This structural feature contributes significantly to acetylcholine's hydrophilic properties and influences its interaction with both synthetic enzymes and postsynaptic receptors. The availability of choline often represents a rate-limiting factor in acetylcholine synthesis, making choline transport mechanisms critical for sustained neurotransmitter production. Following synthesis, acetylcholine undergoes packaging into synaptic vesicles through specialized transporters. Research by Hill and colleagues et al. demonstrated the importance of vesicular storage systems in maintaining neurotransmitter integrity. This vesicular storage system protects the neurotransmitter from premature degradation while maintaining readily releasable pools for rapid synaptic transmission. The vesicular compartmentalization also enables precise control over neurotransmitter release quantities through calcium-dependent exocytotic mechanisms.

Fig.2. Biosynthesis of Acetylcholine

Acetylcholine is synthesized from acetyl CoA and choline by choline acetyltransferase, the rate-limiting step in the pathway. Acetylcholine is then packaged into vesicles by vesicular acetylcholine transporter.

Source: https://med.libretexts.org/Sandboxes/admin/Introduction_to_Neuroscience_%28Hedges%29/03%3A_Neuronal_Communication/3.05%3A_Neurotransmitters-_Acetylcholine

Synaptic Release Mechanisms and Calcium Dynamics

The release of acetylcholine from presynaptic terminals follows the canonical model of calcium-dependent exocytosis established for chemical synaptic transmission. Upon arrival of an action potential at the axon terminal, voltage-gated calcium channels undergo rapid activation, permitting calcium influx that triggers vesicular fusion with the presynaptic membrane. Bullock, Grundfest, Nachmansohn, Rothenburg, and Sterling (1946) et al. provided crucial insights into the relationship between calcium dynamics and acetylcholine release through their studies of anticholinesterase effects on nerve conduction. Their work demonstrated that the temporal precision of acetylcholine release depends critically on the rapid kinetics of calcium channel activation and the spatial organization of calcium sensors relative to vesicle fusion machinery. The calcium-dependent fusion process involves complex molecular interactions between vesicular SNARE proteins and their cognate partners on the presynaptic membrane. This machinery ensures that acetylcholine release occurs with microsecond precision following calcium influx, enabling rapid synaptic transmission essential for behaviors requiring temporal accuracy. The quantity of acetylcholine released per action potential depends on multiple factors, including the number of readily releasable vesicles, the probability of vesicular fusion, and the calcium sensitivity of the release machinery. These parameters can be modulated by various regulatory mechanisms, providing opportunities for synaptic plasticity and adaptation.

Fig.3. Synaptic release Mechanism and Calcium Dynamics of ACh

Source: https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/acetylcholine-release

Receptor Systems and Postsynaptic Signalling

Acetylcholine exerts its physiological effects through interaction with two distinct classes of postsynaptic receptors: nicotinic acetylcholine receptors (nAChRs) and muscarinic acetylcholine receptors (mAChRs). These receptor families exhibit fundamentally different structures, signaling mechanisms, and physiological functions, reflecting the diverse roles of cholinergic transmission across different biological contexts. Nicotinic receptors function as ligand-gated ion channels, mediating rapid depolarization of postsynaptic membranes through sodium influx and potassium efflux. Kuffler (1943) et al. demonstrated the localized nature of nicotinic receptor activation at neuromuscular junctions, showing that acetylcholine application specifically to end-plate regions produced depolarization without affecting adjacent muscle membrane areas. This spatial specificity reflects the concentrated distribution of nicotinic receptors at synaptic sites. The conformational changes induced by acetylcholine binding to nicotinic receptors occur on millisecond timescales, enabling rapid synaptic transmission. Gaskell and colleagues et al. contributed to understanding the temporal dynamics of receptor activation through their studies of cardiac muscle responses. The receptor's intrinsic channel properties, including ion selectivity and conductance characteristics, determine the magnitude and duration of postsynaptic responses. These biophysical properties have been extensively characterized through electrophysiological studies of neuromuscular transmission. Muscarinic receptors, in contrast, couple to intracellular signaling cascades through G-protein-mediated mechanisms. Brown and Eccles et al. provided foundational work on the prolonged effects of muscarinic activation in cardiac tissues. This signaling mode enables more prolonged and modulatory effects compared to the rapid, direct effects mediated by nicotinic receptors. Muscarinic receptor activation can influence multiple cellular processes, including ion channel activity, enzyme function, and gene expression patterns.

Fig.4. Receptor Systems and Postsynaptic Signalling of Ach

Source: https://www.sciencedirect.com/topics/neuroscience/acetylcholine

Neuromuscular Junction Transmission

The neuromuscular junction represents the most thoroughly characterized cholinergic synapse, serving as a prototype for understanding acetylcholine-mediated transmission. The anatomical organization of this synapse, with its high density of nicotinic receptors and efficient acetylcholinesterase activity, optimizes both signal transmission and termination. Cowan (1938) et al. provided foundational evidence for acetylcholine's role in neuromuscular transmission by demonstrating significant muscle depolarization following acetylcholine application, with effects reversible by curare treatment. This work established the pharmacological basis for understanding cholinergic transmission and introduced the concept of competitive receptor antagonism. The end-plate potential represents a specialized form of synaptic potential that exhibits unique biophysical properties. Unlike action potentials, end-plate potentials show graded amplitude responses that depend on the quantity of acetylcholine released and the number of available postsynaptic receptors. The spatial restriction of these potentials to the end-plate region reflects the localized distribution of nicotinic receptors and the efficient removal of acetylcholine by local acetylcholinesterase activity. The safety factor for neuromuscular transmission ensures reliable muscle activation under normal physiological conditions. Grundfest and associates et al. demonstrated the importance of safety margins in synaptic transmission through their comprehensive electrophysiological studies. This safety margin results from the large amplitude of end-plate potentials relative to the threshold for action potential initiation in muscle fibers. However, this safety factor can be compromised by various pathological conditions or pharmacological interventions that affect either acetylcholine release or receptor function.

Fig.5. Neuromuscular Transmission of Ach

The neuromuscular junction (NMJ) is the connection between the end of a nerve and a muscle (skeletal/cardiac/smooth) fiber. The NMJ is where electric signals, called action potentials, generated by motor neurons in the nerve interact with the muscle, causing the muscle to contract.

Source: https://ncdnadayblog.org/2023/04/14/neuromuscular-junction/

Acetylcholinesterase and Signal Termination

The termination of acetylcholine signaling occurs primarily through enzymatic degradation by acetylcholinesterase (AChE), which hydrolyzes the neurotransmitter into acetate and choline components. This enzymatic process represents one of the most efficient reactions in biology, approaching diffusion-limited kinetics that enable rapid signal termination essential for temporal precision in synaptic transmission. Toman et al. (1947) et al. contributed significantly to understanding acetylcholinesterase function through their comparative studies of potassium and diisopropyl fluorphosphonate (DFP) effects on nerve conduction. Their work revealed that anticholinesterase compounds could block conduction through mechanisms distinct from simple membrane depolarization, suggesting complex interactions between acetylcholine metabolism and membrane excitability. The spatial distribution of acetylcholinesterase within synaptic clefts ensures efficient neurotransmitter removal while minimizing interference with ongoing release processes. De Castro and colleagues et al. provided important insights into the specificity of cholinesterase activity through their vagal nerve studies. The enzyme's high catalytic efficiency prevents acetylcholine accumulation that could lead to receptor desensitization or persistent depolarization. This efficient clearance mechanism enables high-frequency synaptic transmission without signal degradation. The products of acetylcholinesterase activity serve important recycling functions. Sterling and colleagues et al. contributed to understanding choline reuptake mechanisms through their studies on cholinergic metabolism. Choline released through acetylcholine hydrolysis undergoes reuptake into presynaptic terminals via high-affinity choline transporters (CHT1), providing substrate for continued neurotransmitter synthesis. This recycling mechanism ensures sustainable acetylcholine production during periods of intense synaptic activity.

Cardiac Muscle Modulation

Acetylcholine's effects on cardiac muscle demonstrate the neurotransmitter's versatility across different tissue types and receptor systems. In cardiac tissue, acetylcholine primarily interacts with muscarinic receptors to produce inhibitory effects on heart rate and contractile force, contrasting with its excitatory actions at neuromuscular junctions. The mechanism of cardiac inhibition involves acetylcholine-induced activation of potassium channels, leading to membrane hyperpolarization and reduced excitability. This hyperpolarization particularly affects the sinoatrial node, the heart's primary pacemaker, resulting in decreased heart rate (negative chronotropy). Additionally, acetylcholine slows conduction through the atrioventricular node, further contributing to cardiac rhythm modulation. Eccles and Brown et al. provided insights into acetylcholine's cardiac effects by proposing that the neurotransmitter prolongs pacemaker recovery processes without necessarily altering surface membrane potentials. This mechanism explains how acetylcholine can modulate cardiac rhythm through subtle changes in cellular excitability rather than dramatic membrane potential shifts. The physiological significance of cholinergic cardiac regulation extends beyond simple heart rate control. Acetylcholine release from vagal nerve terminals provides a mechanism for rapid cardiovascular adjustments in response to changing physiological demands. This regulatory system enables fine-tuning of cardiac output to match metabolic requirements across different behavioral states.

Anticholinesterase Effects and Experimental Insights

The development and application of anticholinesterase compounds have provided crucial tools for understanding cholinergic transmission mechanisms. These compounds, including diisopropyl fluorphosphonate (DFP) and eserine, inhibit acetylcholinesterase activity, leading to acetylcholine accumulation and prolonged receptor activation. Experimental studies using anticholinesterases have revealed complex relationships between acetylcholine metabolism and neural function. The work of various researchers demonstrated that anticholinesterase effects on nerve conduction could not be attributed solely to acetylcholine accumulation, suggesting additional mechanisms involving membrane stability and excitability changes. The differential effects of various anticholinesterases provide insights into the diversity of cholinergic regulatory mechanisms. While some compounds primarily affect acetylcholinesterase activity, others may influence additional aspects of cholinergic transmission, including synthesis, storage, or receptor function. These diverse effects highlight the complexity of cholinergic pharmacology and the need for careful interpretation of experimental results. The therapeutic applications of anticholinesterases in treating conditions such as myasthenia gravis and Alzheimer's disease demonstrate the clinical relevance of understanding cholinergic transmission mechanisms. These applications also illustrate how fundamental research on acetylcholine function translates into practical medical interventions.

Artificial Synapses and Electrical Transmission

The concept of artificial synapses has provided important insights into the relationship between chemical and electrical transmission mechanisms. These experimental preparations demonstrate that nerve cells can influence each other through direct electrical coupling, independent of specialized chemical neurotransmitters. Research on artificial synapses has revealed that electrical transmission can occur when nerve fibers maintain close physical contact, allowing local current flow between cells. Studies on motor and sensory fiber interactions showed that impulses in one fiber could lower the excitation threshold of adjacent fibers by approximately 20%, suggesting significant electrical coupling under appropriate conditions. The investigation of artificial synapses has also contributed to understanding synchronous neural activity patterns. Experiments demonstrating synchronized impulse generation across nerve trunks suggest that electrical coupling may play important roles in coordinating neural network activity, particularly during development or following injury. These findings have implications for understanding both normal neural function and pathological conditions. Abnormal electrical coupling between neurons could contribute to seizure activity or other forms of synchronized pathological activity. Conversely, electrical coupling may provide mechanisms for neural network coordination that complement chemical synaptic transmission.

Junction Potentials and Synaptic Integration

The discovery of junction potentials has fundamentally advanced understanding of synaptic transmission mechanisms across different neural systems. These localized electrical events, including end-plate potentials in muscle and synaptic potentials in sympathetic ganglia, represent intermediate stages in synaptic transmission that bridge the gap between neurotransmitter release and postsynaptic action potential generation. Junction potentials exhibit characteristic temporal profiles featuring rapid rise times followed by exponential decay phases lasting much longer than presynaptic action potentials. Research on end-plate potentials has shown that these events can initiate postsynaptic impulses during their rising phase while also providing facilitatory effects throughout their duration. The properties of junction potentials reflect the underlying mechanisms of neurotransmitter action and removal. The initial rapid rise corresponds to neurotransmitter binding and receptor activation, while the prolonged decay phase reflects the time course of neurotransmitter clearance from synaptic sites. Anticholinesterase treatment can dramatically prolong the decay phase, confirming the role of enzymatic degradation in signal termination. Synaptic integration processes depend critically on the temporal and spatial summation of junction potentials. Multiple synaptic inputs can combine to influence postsynaptic excitability, with the final outcome depending on the precise timing and magnitude of individual synaptic events. This integration process enables complex computational functions within neural networks.

Sympathetic Ganglia and Cholinergic Transmission

Sympathetic ganglia provide important models for understanding cholinergic transmission in the central nervous system. The synaptic mechanisms operating in these structures share many features with neuromuscular transmission while also exhibiting unique properties related to their role in autonomic nervous system function. Preganglionic nerve stimulation in sympathetic ganglia produces synaptic potentials that exhibit similarities to end-plate potentials in muscle. Studies by De Castro et al. revealed unexpected findings regarding the specificity of cholinergic transmission, showing that sensory fibers not expected to contain acetylcholine could nevertheless establish functional connections with ganglion cells. The pharmacological properties of ganglionic transmission demonstrate both similarities to and differences from neuromuscular transmission. Eserine treatment, which typically enhances cholinergic transmission, showed variable effects depending on the specific fiber types involved in synaptic connections. These findings suggest that cholinergic transmission mechanisms may exhibit greater diversity than initially appreciated. The role of acetylcholine in ganglionic transmission extends beyond simple excitatory effects. The neurotransmitter may also influence ganglionic integration processes, modulating the relationship between preganglionic input patterns and postganglionic output. This modulatory function provides mechanisms for adaptive changes in autonomic nervous system responsiveness.

Contemporary Perspectives and Future Directions

Current understanding of acetylcholine function continues to evolve with advancing experimental techniques and theoretical frameworks. Modern approaches combining molecular biology, electrophysiology, and computational modeling provide increasingly detailed pictures of cholinergic transmission mechanisms at multiple levels of organization. The development of optogenetic tools and advanced imaging techniques enables real-time visualization of acetylcholine release and receptor activation in living neural tissue. These approaches promise to reveal spatial and temporal aspects of cholinergic transmission that were previously inaccessible to experimental investigation. Computational models of cholinergic synapses incorporating detailed molecular mechanisms provide frameworks for predicting synaptic behavior under various conditions. These models can guide experimental design and help interpret complex experimental results involving multiple interacting mechanisms. The therapeutic relevance of acetylcholine research continues to expand with growing understanding of cholinergic system involvement in neurological and psychiatric disorders. Developing more selective and effective cholinergic therapies requires continued advancement in understanding fundamental transmission mechanisms.

Table No. 1. Functional, Mechanistic, and Experimental Perspectives on Acetylcholinesterase and Cholinergic Transmission

Section

Key Mechanism or Concept

Physiological/Experimental Insight

Reference/Contributor(s)

Acetylcholinesterase and Signal Termination

AChE hydrolyzes acetylcholine into acetate and choline, enabling rapid signal termination

Rapid clearance prevents desensitization and ensures high-frequency synaptic fidelity

Toman et al. (1947); De Castro et al.; Sterling et al.

Choline Recycling

Choline reuptake by CHT1 ensures resynthesis of ACh

Supports continuous neurotransmission during intense activity

Sterling et al.

Cardiac Muscle Modulation

ACh activates muscarinic receptors → K? channel opening → SA node hyperpolarization

Negative chronotropic effect; vagal input modulates cardiac output

Eccles and Brown et al.

Anticholinesterase Effects

Inhibit AChE → Prolonged ACh action at synapses

Highlights roles beyond ACh accumulation, including membrane excitability

Toman et al.; Various researchers

Therapeutic Application

Use in myasthenia gravis and Alzheimer’s disease

Shows translational impact of cholinergic studies

Clinical pharmacological research

Artificial Synapses and Electrical Coupling

Direct electrical coupling via low-resistance pathways

Demonstrates synchronized impulse propagation and fiber interaction

Studies on motor-sensory fiber interactions

Junction Potentials and Synaptic Integration

End-plate potentials represent intermediate postsynaptic electrical events

Reveal time course of ACh action; prolonged by AChE inhibitors

Experimental neuromuscular research

Synaptic Summation

Spatial and temporal summation of junction potentials

Enables integration of multiple inputs for complex output patterns

Synaptic physiology studies

Sympathetic Ganglia and Cholinergic Transmission

Preganglionic stimulation → graded synaptic potentials in ganglia

Shows diversity and adaptability of cholinergic mechanisms

De Castro et al.; Eserine pharmacological studies

Future Directions

Optogenetics, real-time imaging, computational modeling

Enhances understanding of spatiotemporal cholinergic dynamics

Contemporary molecular neuroscience

Therapeutic Innovations

Molecular-level targeting of cholinergic systems

Potential treatments for neurodegeneration and psychiatric conditions

Current translational research

CONCLUSION

Acetylcholine represents a paradigmatic neurotransmitter whose study has fundamentally shaped modern understanding of synaptic transmission mechanisms. From its initial identification to contemporary molecular investigations, acetylcholine research has provided crucial insights into how chemical signals mediate neural communication. The neurotransmitter's diverse functions, spanning from rapid neuromuscular transmission to modulatory effects in cardiac and neural tissues, illustrate the versatility of cholinergic signaling systems. The experimental approaches developed for studying acetylcholine, including the use of pharmacological tools and artificial synapse preparations, have established methodological foundations that extend far beyond cholinergic research. These approaches continue to inform investigations of other neurotransmitter systems and contribute to broader understanding of neural network function. Future research directions in acetylcholine neurobiology will likely focus on integrating molecular mechanisms with systems-level functions, developing more sophisticated therapeutic interventions, and understanding cholinergic system roles in complex behaviours and disease states. The fundamental principles established through decades of acetylcholine research provide solid foundations for these continuing investigations. The significance of acetylcholine in neuroscience extends beyond its specific functions to encompass its role as a model system for understanding general principles of neural communication. As neuroscience continues to evolve, the lessons learned from acetylcholine research will undoubtedly continue to inform and guide future discoveries in neural transmission mechanisms.

REFERENCE

  1. Albuquerque, E. X., Pereira, E. F., Alkondon, M., & Rogers, S. W. (2009). Mammalian nicotinic acetylcholine receptors: From structure to function. Physiological Reviews, 89(1), 73-120. https://doi.org/10.1152/physrev.00015.2008
  2. Ballinger, E. C., Ananth, M., Talmage, D. A., & Role, L. W. (2016). Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline. Neuron, 91(6), 1199-1218. https://doi.org/10.1016/j.neuron.2016.09.006
  3. Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science, 217(4558), 408-414. https://doi.org/10.1126/science.7046051
  4. Bekkers, J. M., & Stevens, C. F. (1991). Excitatory and inhibitory autaptic currents in isolated hippocampal neurons maintained in cell culture. Proceedings of the National Academy of Sciences, 88(17), 7834-7838. https://doi.org/10.1073/pnas.88.17.7834
  5. Burnstock, G. (2004). Cotransmission. Current Opinion in Pharmacology, 4(1), 47-52. https://doi.org/10.1016/j.coph.2003.08.001
  6. Changeux, J. P. (2010). Nicotine addiction and nicotinic receptors: Lessons from genetically modified mice. Nature Reviews Neuroscience, 11(6), 389-401. https://doi.org/10.1038/nrn2849
  7. Changeux, J. P., & Edelstein, S. J. (2005). Nicotinic acetylcholine receptors: From molecular biology to cognition. Odile Jacob/Johns Hopkins University Press.
  8. Caulfield, M. P., & Birdsall, N. J. (1998). International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacological Reviews, 50(2), 279-290.
  9. Dani, J. A., & Bertrand, D. (2007). Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annual Review of Pharmacology and Toxicology, 47, 699-729. https://doi.org/10.1146/annurev.pharmtox.47.120505.105214
  10. Disney, A. A., Aoki, C., & Hawken, M. J. (2007). Gain modulation by nicotine in macaque v1. Neuron, 56(4), 701-713. https://doi.org/10.1016/j.neuron.2007.09.034
  11. Eckenstein, F. P., Baughman, R. W., & Quinn, J. (1988). An anatomical study of cholinergic innervation in rat cerebral cortex. Neuroscience, 25(2), 457-474. https://doi.org/10.1016/0306-4522(88)90251-5
  12. Ferguson, S. M., Savchenko, V., Apparsundaram, S., Zwick, M., Wright, J., Heilman, C. J., ... & Blakely, R. D. (2003). Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. Journal of Neuroscience, 23(30), 9697-9709. https://doi.org/10.1523/JNEUROSCI.23-30-09697.2003
  13. Gotti, C., Zoli, M., & Clementi, F. (2006). Brain nicotinic acetylcholine receptors: Native subtypes and their relevance. Trends in Pharmacological Sciences, 27(9), 482-491. https://doi.org/10.1016/j.tips.2006.07.004
  14. Grady, S. R., Drenan, R. M., Breining, S. R., Yohannes, D., Wageman, C. R., Fedorov, N. B., ... & Lester, H. A. (2010). Structural differences determine the relative selectivity of nicotinic compounds for native α4β2*-, α6β2*-, α3β4*- and α7-nicotine acetylcholine receptors. Neuropharmacology, 58(7), 1054-1066. https://doi.org/10.1016/j.neuropharm.2010.01.013
  15. Hasselmo, M. E., & McGaughy, J. (2004). High acetylcholine levels set circuit dynamics for attention and encoding and low acetylcholine levels set dynamics for consolidation. Progress in Brain Research, 145, 207-231. https://doi.org/10.1016/S0079-6123(03)45015-2
  16. Hille, B. (2001). Ion channels of excitable membranes (3rd ed.). Sinauer Associates.
  17. Jones, B. E. (2003). Arousal systems. Frontiers in Bioscience, 8, s438-s451. https://doi.org/10.2741/1074
  18. Katz, B., & Miledi, R. (1967). The timing of calcium action during neuromuscular transmission. Journal of Physiology, 189(3), 535-544. https://doi.org/10.1113/jphysiol.1967.sp008183
  19. Lee, M. G., Hassani, O. K., Alonso, A., & Jones, B. E. (2005). Cholinergic basal forebrain neurons burst with theta during waking and paradoxical sleep. Journal of Neuroscience, 25(17), 4365-4369. https://doi.org/10.1523/JNEUROSCI.0178-05.2005
  20. Levy, R. B., Reyes, A. D., & Aoki, C. (2006). Nicotinic and muscarinic reduction of unitary excitatory postsynaptic potentials in sensory cortex; dual intracellular recording in vitro. Journal of Neurophysiology, 95(4), 2155-2166. https://doi.org/10.1152/jn.00890.2005
  21. Mansvelder, H. D., & McGehee, D. S. (2000). Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron, 27(2), 349-357. https://doi.org/10.1016/S0896-6273(00)00042-8
  22. Mesulam, M. M. (2004). The cholinergic lesion of Alzheimer's disease: Pivotal factor or side show? Learning & Memory, 11(1), 43-49. https://doi.org/10.1101/lm.69204
  23. Miasnikov, A. A., Chen, J. C., Gross, N., Poytress, B. S., & Weinberger, N. M. (2006). Motivationally neutral stimulation of the nucleus basalis induces specific behavioral memory. Neurobiology of Learning and Memory, 86(2), 125-137. https://doi.org/10.1016/j.nlm.2006.02.001
  24. Nashmi, R., Xiao, C., Deshpande, P., McKinney, S., Grady, S. R., Whiteaker, P., ... & Lester, H. A. (2007). Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: Basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. Journal of Neuroscience, 27(31), 8202-8218. https://doi.org/10.1523/JNEUROSCI.2199-07.2007
  25. Parikh, V., Kozak, R., Martinez, V., & Sarter, M. (2007). Prefrontal acetylcholine release controls cue detection on multiple timescales. Neuron, 56(1), 141-154. https://doi.org/10.1016/j.neuron.2007.08.025
  26. Picciotto, M. R., Higley, M. J., & Mineur, Y. S. (2012). Acetylcholine as a neuromodulator: Cholinergic signaling shapes nervous system function and behavior. Neuron, 76(1), 116-129. https://doi.org/10.1016/j.neuron.2012.08.036
  27. Prince, D. A., & Stevens, C. F. (1992). Acetylcholine. In G. J. Siegel, B. W. Agranoff, R. W. Albers, & P. B. Molinoff (Eds.), Basic neurochemistry: Molecular, cellular and medical aspects (5th ed., pp. 213-228). Raven Press.
  28. Sarter, M., Hasselmo, M. E., Bruno, J. P., & Givens, B. (2005). Unraveling the attentional functions of cortical cholinergic inputs: Interactions between signal-driven and cognitive modulation of signal detection. Brain Research Reviews, 48(1), 98-111. https://doi.org/10.1016/j.brainresrev.2004.08.006
  29. Sarter, M., & Parikh, V. (2005). Choline transporters, cholinergic transmission and cognition. Nature Reviews Neuroscience, 6(1), 48-56. https://doi.org/10.1038/nrn1588
  30. Takács, V. T., Klausberger, T., Somogyi, P., Freund, T. F., & Gulyás, A. I. (2018). Co-transmission of acetylcholine and GABA regulates hippocampal states. Nature Communications, 9(1), 2848. https://doi.org/10.1038/s41467-018-05136-1
  31. Turrini, P., Casu, M. A., Wong, T. P., De Koninck, Y., Ribeiro-da-Silva, A., & Cuello, A. C. (2001). Cholinergic nerve terminals establish classical synapses in the rat cerebral cortex: Synaptic pattern and age-related atrophy. Neuroscience, 105(2), 277-285. https://doi.org/10.1016/S0306-4522(01)00172-5
  32. Unwin, N. (2005). Refined structure of the nicotinic acetylcholine receptor at 4Å resolution. Journal of Molecular Biology, 346(4), 967-989. https://doi.org/10.1016/j.jmb.2004.12.031
  33. Wess, J. (2004). Muscarinic acetylcholine receptor knockout mice: Novel phenotypes and clinical implications. Annual Review of Pharmacology and Toxicology, 44, 423-450. https://doi.org/10.1146/annurev.pharmtox.44.101802.121622
  34. Yakel, J. L. (2013). Cholinergic receptors: Functional role of nicotinic ACh receptors in brain circuits and disease. Pflügers Archiv-European Journal of Physiology, 465(4), 441-450. https://doi.org/10.1007/s00424-013-1274-2
  35. Zhou, F. M., Liang, Y., & Dani, J. A. (2001). Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nature Neuroscience, 4(12), 1224-1229. https://doi.org/10.1038/nn769.

Reference

  1. Albuquerque, E. X., Pereira, E. F., Alkondon, M., & Rogers, S. W. (2009). Mammalian nicotinic acetylcholine receptors: From structure to function. Physiological Reviews, 89(1), 73-120. https://doi.org/10.1152/physrev.00015.2008
  2. Ballinger, E. C., Ananth, M., Talmage, D. A., & Role, L. W. (2016). Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline. Neuron, 91(6), 1199-1218. https://doi.org/10.1016/j.neuron.2016.09.006
  3. Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science, 217(4558), 408-414. https://doi.org/10.1126/science.7046051
  4. Bekkers, J. M., & Stevens, C. F. (1991). Excitatory and inhibitory autaptic currents in isolated hippocampal neurons maintained in cell culture. Proceedings of the National Academy of Sciences, 88(17), 7834-7838. https://doi.org/10.1073/pnas.88.17.7834
  5. Burnstock, G. (2004). Cotransmission. Current Opinion in Pharmacology, 4(1), 47-52. https://doi.org/10.1016/j.coph.2003.08.001
  6. Changeux, J. P. (2010). Nicotine addiction and nicotinic receptors: Lessons from genetically modified mice. Nature Reviews Neuroscience, 11(6), 389-401. https://doi.org/10.1038/nrn2849
  7. Changeux, J. P., & Edelstein, S. J. (2005). Nicotinic acetylcholine receptors: From molecular biology to cognition. Odile Jacob/Johns Hopkins University Press.
  8. Caulfield, M. P., & Birdsall, N. J. (1998). International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacological Reviews, 50(2), 279-290.
  9. Dani, J. A., & Bertrand, D. (2007). Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annual Review of Pharmacology and Toxicology, 47, 699-729. https://doi.org/10.1146/annurev.pharmtox.47.120505.105214
  10. Disney, A. A., Aoki, C., & Hawken, M. J. (2007). Gain modulation by nicotine in macaque v1. Neuron, 56(4), 701-713. https://doi.org/10.1016/j.neuron.2007.09.034
  11. Eckenstein, F. P., Baughman, R. W., & Quinn, J. (1988). An anatomical study of cholinergic innervation in rat cerebral cortex. Neuroscience, 25(2), 457-474. https://doi.org/10.1016/0306-4522(88)90251-5
  12. Ferguson, S. M., Savchenko, V., Apparsundaram, S., Zwick, M., Wright, J., Heilman, C. J., ... & Blakely, R. D. (2003). Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. Journal of Neuroscience, 23(30), 9697-9709. https://doi.org/10.1523/JNEUROSCI.23-30-09697.2003
  13. Gotti, C., Zoli, M., & Clementi, F. (2006). Brain nicotinic acetylcholine receptors: Native subtypes and their relevance. Trends in Pharmacological Sciences, 27(9), 482-491. https://doi.org/10.1016/j.tips.2006.07.004
  14. Grady, S. R., Drenan, R. M., Breining, S. R., Yohannes, D., Wageman, C. R., Fedorov, N. B., ... & Lester, H. A. (2010). Structural differences determine the relative selectivity of nicotinic compounds for native α4β2*-, α6β2*-, α3β4*- and α7-nicotine acetylcholine receptors. Neuropharmacology, 58(7), 1054-1066. https://doi.org/10.1016/j.neuropharm.2010.01.013
  15. Hasselmo, M. E., & McGaughy, J. (2004). High acetylcholine levels set circuit dynamics for attention and encoding and low acetylcholine levels set dynamics for consolidation. Progress in Brain Research, 145, 207-231. https://doi.org/10.1016/S0079-6123(03)45015-2
  16. Hille, B. (2001). Ion channels of excitable membranes (3rd ed.). Sinauer Associates.
  17. Jones, B. E. (2003). Arousal systems. Frontiers in Bioscience, 8, s438-s451. https://doi.org/10.2741/1074
  18. Katz, B., & Miledi, R. (1967). The timing of calcium action during neuromuscular transmission. Journal of Physiology, 189(3), 535-544. https://doi.org/10.1113/jphysiol.1967.sp008183
  19. Lee, M. G., Hassani, O. K., Alonso, A., & Jones, B. E. (2005). Cholinergic basal forebrain neurons burst with theta during waking and paradoxical sleep. Journal of Neuroscience, 25(17), 4365-4369. https://doi.org/10.1523/JNEUROSCI.0178-05.2005
  20. Levy, R. B., Reyes, A. D., & Aoki, C. (2006). Nicotinic and muscarinic reduction of unitary excitatory postsynaptic potentials in sensory cortex; dual intracellular recording in vitro. Journal of Neurophysiology, 95(4), 2155-2166. https://doi.org/10.1152/jn.00890.2005
  21. Mansvelder, H. D., & McGehee, D. S. (2000). Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron, 27(2), 349-357. https://doi.org/10.1016/S0896-6273(00)00042-8
  22. Mesulam, M. M. (2004). The cholinergic lesion of Alzheimer's disease: Pivotal factor or side show? Learning & Memory, 11(1), 43-49. https://doi.org/10.1101/lm.69204
  23. Miasnikov, A. A., Chen, J. C., Gross, N., Poytress, B. S., & Weinberger, N. M. (2006). Motivationally neutral stimulation of the nucleus basalis induces specific behavioral memory. Neurobiology of Learning and Memory, 86(2), 125-137. https://doi.org/10.1016/j.nlm.2006.02.001
  24. Nashmi, R., Xiao, C., Deshpande, P., McKinney, S., Grady, S. R., Whiteaker, P., ... & Lester, H. A. (2007). Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: Basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. Journal of Neuroscience, 27(31), 8202-8218. https://doi.org/10.1523/JNEUROSCI.2199-07.2007
  25. Parikh, V., Kozak, R., Martinez, V., & Sarter, M. (2007). Prefrontal acetylcholine release controls cue detection on multiple timescales. Neuron, 56(1), 141-154. https://doi.org/10.1016/j.neuron.2007.08.025
  26. Picciotto, M. R., Higley, M. J., & Mineur, Y. S. (2012). Acetylcholine as a neuromodulator: Cholinergic signaling shapes nervous system function and behavior. Neuron, 76(1), 116-129. https://doi.org/10.1016/j.neuron.2012.08.036
  27. Prince, D. A., & Stevens, C. F. (1992). Acetylcholine. In G. J. Siegel, B. W. Agranoff, R. W. Albers, & P. B. Molinoff (Eds.), Basic neurochemistry: Molecular, cellular and medical aspects (5th ed., pp. 213-228). Raven Press.
  28. Sarter, M., Hasselmo, M. E., Bruno, J. P., & Givens, B. (2005). Unraveling the attentional functions of cortical cholinergic inputs: Interactions between signal-driven and cognitive modulation of signal detection. Brain Research Reviews, 48(1), 98-111. https://doi.org/10.1016/j.brainresrev.2004.08.006
  29. Sarter, M., & Parikh, V. (2005). Choline transporters, cholinergic transmission and cognition. Nature Reviews Neuroscience, 6(1), 48-56. https://doi.org/10.1038/nrn1588
  30. Takács, V. T., Klausberger, T., Somogyi, P., Freund, T. F., & Gulyás, A. I. (2018). Co-transmission of acetylcholine and GABA regulates hippocampal states. Nature Communications, 9(1), 2848. https://doi.org/10.1038/s41467-018-05136-1
  31. Turrini, P., Casu, M. A., Wong, T. P., De Koninck, Y., Ribeiro-da-Silva, A., & Cuello, A. C. (2001). Cholinergic nerve terminals establish classical synapses in the rat cerebral cortex: Synaptic pattern and age-related atrophy. Neuroscience, 105(2), 277-285. https://doi.org/10.1016/S0306-4522(01)00172-5
  32. Unwin, N. (2005). Refined structure of the nicotinic acetylcholine receptor at 4Å resolution. Journal of Molecular Biology, 346(4), 967-989. https://doi.org/10.1016/j.jmb.2004.12.031
  33. Wess, J. (2004). Muscarinic acetylcholine receptor knockout mice: Novel phenotypes and clinical implications. Annual Review of Pharmacology and Toxicology, 44, 423-450. https://doi.org/10.1146/annurev.pharmtox.44.101802.121622
  34. Yakel, J. L. (2013). Cholinergic receptors: Functional role of nicotinic ACh receptors in brain circuits and disease. Pflügers Archiv-European Journal of Physiology, 465(4), 441-450. https://doi.org/10.1007/s00424-013-1274-2
  35. Zhou, F. M., Liang, Y., & Dani, J. A. (2001). Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nature Neuroscience, 4(12), 1224-1229. https://doi.org/10.1038/nn769.

Photo
Arnab Roy
Corresponding author

Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Photo
Rashmi Kumari
Co-author

Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Photo
Naba Kishor Gorai
Co-author

Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Photo
Niraj Kumar
Co-author

Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Photo
Ayush Kumar Verma
Co-author

Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Photo
Manish Kumar Singh
Co-author

Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Photo
Mona Singh
Co-author

Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Photo
Annu Priya
Co-author

Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Photo
Satyam Sundram Mahto
Co-author

Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Photo
Satish Kumar
Co-author

Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Photo
Rajkumar Singh
Co-author

Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Photo
Vivek Kumar
Co-author

Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Photo
Rupesh Kumar
Co-author

Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Photo
Karan Kumar
Co-author

Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Photo
Aman Sinha
Co-author

Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Photo
Mahesh Kumar Yadav
Co-author

Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Rashmi Kumari, Naba Kishor Gorai, Niraj Kumar, Ayush Kumar Verma, Manish Kumar Singh, Mona Singh, Annu Priya, Satyam Sundram Mahto, Satish Kumar, Rajkumar Singh, Vivek Kumar, Rupesh Kumar, Karan Kumar, Aman Sinha, Mahesh Kumar Yadav, Arnab Roy*, Acetylcholine-Mediated Synaptic Transmission: From Molecular Mechanisms to Physiological Significance in Neural Communication, Int. J. Sci. R. Tech., 2025, 2 (8), 73-83. https://doi.org/10.5281/zenodo.16754309

More related articles
Beyond Classical Categories: A Modern Taxonomic Fr...
Arnab Roy, Nisha Kumari , Pratik Mondal , Ravi Kumar , Balraj Kum...
Paracetamol-Induced Toxicity: A Review of the Side...
Arnab Roy, Kumari Shiwani Shivam , Divyansh Kumar Gourav , Manish...
Formulation and Evaluation Fast Disintegrating Tab...
Harshal Gosavi, Dr. Avish Maru, Jayshri Bhadane, ...
Development and Experimental Evaluation of Silver Nanoparticles with Anti-Microb...
Sanket Dhangare, Vitthal Chopade, Chinmayee Chavan, Aditya Kasar, Mahesh Reddy , ...
Credit Card Fraud Detection Based on Feature Selection and Enhanced Support Vect...
Shan Ali Abdula, Hersh Fakhradin Aziz, Pavel Ali Abdula, Salam Aham Ali, Pehraw Salam Abdalqadir, ...
Related Articles
Amyotrophic Lateral Sclerosis: A Comprehensive Review of Pathophysiology, Clinic...
Arnab Roy, Shruti Kumari , Bindu Kumari , Abhinav Kumar , Divya Kumari , Indu Sharma , Ashish Kumar...
The Economics Orphan Drugs: Supply Chains, Data Security, and Transparency...
Utkarsha Sawant, Pratiksha Ghodake, Shrushti Shahane, Swapnil Kale, Sneha Kanase, ...
Esterification of Metronidazole and its Complexation with ? -Cyclodextrin: A Str...
Rahul Patil, Sandip Patil, Gaurav Gupta, Harpalsing Girase, ...
Beyond Classical Categories: A Modern Taxonomic Framework for Brain Neurotransmi...
Arnab Roy, Nisha Kumari , Pratik Mondal , Ravi Kumar , Balraj Kumar , Dheeraj Prasad , Manish Kumar ...
More related articles
Beyond Classical Categories: A Modern Taxonomic Framework for Brain Neurotransmi...
Arnab Roy, Nisha Kumari , Pratik Mondal , Ravi Kumar , Balraj Kumar , Dheeraj Prasad , Manish Kumar ...
Paracetamol-Induced Toxicity: A Review of the Side Effects Associated with Exces...
Arnab Roy, Kumari Shiwani Shivam , Divyansh Kumar Gourav , Manish Kumar , Satyam Kumar Prajapati , G...
Formulation and Evaluation Fast Disintegrating Tablet of Telmisartan...
Harshal Gosavi, Dr. Avish Maru, Jayshri Bhadane, ...
Beyond Classical Categories: A Modern Taxonomic Framework for Brain Neurotransmi...
Arnab Roy, Nisha Kumari , Pratik Mondal , Ravi Kumar , Balraj Kumar , Dheeraj Prasad , Manish Kumar ...
Paracetamol-Induced Toxicity: A Review of the Side Effects Associated with Exces...
Arnab Roy, Kumari Shiwani Shivam , Divyansh Kumar Gourav , Manish Kumar , Satyam Kumar Prajapati , G...
Formulation and Evaluation Fast Disintegrating Tablet of Telmisartan...
Harshal Gosavi, Dr. Avish Maru, Jayshri Bhadane, ...